Based on providing a basis for investment decision-making and preparation of design task book for the project of traditional Chinese medicine extraction and API production base, Zhiyan Consulting has launched the "Feasibility Study Report on the Project of Traditional Chinese Medicine Extraction and API Production Base" (hereinafter referred to as the "Feasibility Study Report"). The "Feasibility Study Report" aims to demonstrate and evaluate the market feasibility, policy feasibility, organizational feasibility, technical feasibility, environmental feasibility, financial feasibility and other multiple elements of the project implementation in an in-depth, specific, detailed and perfect manner, so as to determine the optimal plan to produce good social and economic benefits, so as to provide a scientific basis for investment decision-making and administrative approval.
Feasibility Study Report on Traditional Chinese Medicine Extraction and API Production Base Project
In order to ensure the accuracy of the industry and project data involved in the "Feasibility Study Report" and the rigor of demonstration and analysis, the Zhiyan consulting research team carries out data collection through multiple channels such as annual reports of listed companies, manufacturer research, dealer discussions, and expert verification, and conducts rigorous demonstration of the data and content, so as to deeply analyze the feasibility of the project in terms of technical, economic and social conditions, so that the project construction unit (enterprise) can Comprehensively understand the market prospects and benefits of the project from multiple aspects, and then help the project to follow up the administrative examination and approval, land acquisition approval, bank loans, and investment cooperation.
Catalogue of Feasibility Study Report on Traditional Chinese Medicine Extraction and API Production Base Project
Traditional Chinese medicine refers to the drugs used to prevent and treat diseases under the guidance of traditional Chinese medicine theory, mainly derived from natural medicines and their processed products, including botanical medicines, animal medicines, mineral medicines and some chemical and biological products. Since most of traditional Chinese medicine is botanical, there is a saying that "all medicines are herb-based". Traditional Chinese medicine mainly includes Chinese herbal medicines, Chinese patent medicines, Chinese medicine decoction pieces, Chinese medicine formula granules and Chinese medicine injections, among which Chinese herbal medicines are primary products, while Chinese patent medicines and Chinese medicine decoction pieces, Chinese medicine formula granules, Chinese medicine injections and Chinese medicine health products are terminal products that can be used directly.
With the continuous emergence of chemical toxicity and side effects, the increasing number of iatrogenic and drug-induced diseases, and the green boom of "returning to nature" is widely emerging around the world, traditional Chinese medicine has attracted more and more attention due to its natural origin, small side effects, exact efficacy, and relatively low price. According to the data, the scale of the mainland Chinese medicine market will reach 430.2 billion yuan in 2021.
The current situation of the Chinese medicine industry
Since 2019, the mainland has successively promulgated a number of policies and measures to promote the inheritance, innovation and development of traditional Chinese medicine. Especially since 2023, a number of favorable policies have been ushered in in the field of traditional Chinese medicine: the State Food and Drug Administration has successively issued the "Several Measures on Further Strengthening the Scientific Supervision of Traditional Chinese Medicine to Promote the Inheritance, Innovation and Development of Traditional Chinese Medicine" and "Special Provisions on the Registration and Management of Traditional Chinese Medicine", on the one hand, strengthening the quality management of traditional Chinese medicines, clarifying the work specifications, and improving the review and approval mechanism of traditional Chinese medicines, on the other hand, it has also pointed out the direction for the research and development, registration and future product pipeline development of enterprises.
Policies for the Chinese medicine industry
Under the background of continuous favorable national policies, mainland Chinese medicine enterprises have seized the policy opportunities, given full play to their own advantages, and gradually gained wings, and the strong continue to consolidate their leading position in the high-quality development of the Chinese medicine industry. At present, there are a large number of enterprises in the traditional Chinese medicine industry in mainland China, the market concentration is low, and the competition is fierce.
As of December 29, 2023, the market value of 73 listed companies in the traditional Chinese medicine industry totaled 1,019.824 billion yuan. The market value of 12 listed companies exceeded 20 billion yuan, and the market value of 3 listed companies exceeded 50 billion yuan. Among them, Pien Tze Huang has the highest market value of 145.997 billion yuan, and Yunnan Baiyao and Tongrentang rank second and third.
The competitive landscape of the Chinese medicine industry
The total investment of the traditional Chinese medicine extraction and API production base project is ×× million yuan, and the source of funds is the company's own funds. The project will build ×× square meters of extraction and pre-treatment workshop, synthesis workshop, pilot plant, power center and power distribution room, warehouse and logistics complex, purchase ×× sets of production process equipment and public supporting equipment to meet the needs of product production, lay electricity, heat, water supply and drainage, fire protection and other pipelines in the production plant area, and complete the construction of roads, greening and other supporting projects.
Overview of the project of traditional Chinese medicine extraction and API production base
The "Feasibility Study Report on the Extraction of Traditional Chinese Medicine and API Production Base Project" contains professional analysis, careful design and scientific demonstration. It is an important research achievement of Zhiyan Consulting, a powerful embodiment of Zhiyan Consulting's leading industry reform, affection for the industry, and implementation of its mission, and an important basis for investment decisions made by project construction units (enterprises). Zhiyan Consulting has formed a complete and three-dimensional think tank system, serving the government, enterprises, financial institutions, etc., for many years, providing science and technology, consulting, education, ecology, capital and other services.
Report Table of Contents Framework:
1. Overview
(1) Project overview
1. Project name and construction site
2. Project construction content
3. Project construction progress
4. Project benefit analysis
5. Risk warning
(2) Enterprise profile
(3) Basis for compilation
(4) Main conclusions and recommendations
2. Project construction background, demand analysis and output plan
(1) Compliance with planning policies
(2) Analysis of the development strategy needs of enterprises
(3) Analysis of project market demand
(4) The content, scale and output plan of the project construction
(5) Project business model
3. Project site selection and element guarantee
(1) Project site selection or route selection
(2) Project construction conditions
(3) Element Warranty Analysis
Fourth, the project construction plan
(1) Technical solutions
(2) Equipment plan
(3) Engineering plan
(4) Resource development plan
(5) Compensation (resettlement) plan for land and sea expropriation
(6) Digital solutions
(7) Construction management plan
5. Project operation plan
(A) production and operation plan
(2) Security guarantee plan
(3) Operation and management plan
6. Project investment, financing and financial plan
(1) Investment estimates
(2) Profitability analysis
(3) Financing plan
(4) Analysis of debt solvency
(5) Financial sustainability analysis
7. Analysis of the impact of the project
(1) Economic impact analysis
(2) Social impact analysis
(3) Ecological environmental impact analysis
(4) Analysis of the effect of resource and energy utilization
(5) Analysis of carbon peak and carbon neutrality
8. Project risk management and control plan
(1) Risk identification and evaluation
1. Policy risk
2. Manage risk
3. Capital risk
(2) Risk management and control plan
(3) Risk contingency plan
9. Conclusions and recommendations of the study
(1) Main research conclusions
(2) Questions and suggestions
10. Schedules, drawings and annexes
As a leading brand in the field of industrial consulting in China, Zhiyan Consulting takes "driving industrial development with information and empowering enterprise investment decision-making" as its brand concept. The company integrates quantitative analysis and qualitative analysis methods, uses self-developed algorithms, combines industry cross-big data, and excavates the root causes behind quantitative data through diversified analysis, analyzes the logic behind qualitative content, objectively and truthfully explains the current situation of the industry, prudently predicts the future development trend of the industry, and provides customers with professional industry analysis, market research, data insights, strategic consulting and related solutions to help customers improve their cognitive level, profitability and comprehensive competitiveness. The main services include high-quality industry research reports, special customization, monthly topics, feasibility study reports, business plans, industrial planning, etc. Provide weekly/monthly/quarterly/annual reports and other regular reports and customized data, covering policy monitoring, corporate dynamics, industry data, product price changes, investment and financing overview, market opportunities and risk analysis, etc.